Cancer Vaccine

Pancreatic cancer stopped by dendritic cell vaccine

Published in Vaccine Weekly, December 25th, 2002

by Maria G. Essig, MS, ELS, senior medical writer - A vaccine containing dendritic cells (DC) effectively inhibited the growth of established malignant pancreatic tumors in hamsters, according to a report in the journal, Cancer Letters.

"Because the prognosis of patients with pancreatic cancer is very poor, development of a novel approach for treatment of this disease is vital," commented Yasuto Akiyama and colleagues at the National Cancer Center Research Institute in Japan and the National Cancer Institute in the United States.

The investigators used the HPD1NR hamster pancreatic cancer model to test the ability of a DC-based vaccine to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2002-12-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry